Viemed Healthcare, Inc.
VMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.72 | 0.37 | -1.35 | -0.31 |
| FCF Yield | 0.42% | 6.35% | 1.66% | 1.33% |
| EV / EBITDA | 7.09 | 8.13 | 11.49 | 8.44 |
| Quality | ||||
| ROIC | 8.96% | 8.17% | 5.76% | 8.24% |
| Gross Margin | 59.40% | 61.63% | 60.99% | 62.71% |
| Cash Conversion Ratio | 3.43 | 4.41 | 4.46 | 2.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.33% | 16.06% | 1.87% | 13.41% |
| Free Cash Flow Growth | -93.11% | 294.21% | 76.30% | -87.53% |
| Safety | ||||
| Net Debt / EBITDA | -0.25 | -0.07 | -0.68 | -1.00 |
| Interest Coverage | 23.07 | 33.80 | 41.89 | 36.42 |
| Efficiency | ||||
| Inventory Turnover | 21.08 | 15.17 | 15.15 | 17.77 |
| Cash Conversion Cycle | 20.43 | 22.34 | 46.73 | 39.35 |